Elevance Health (ELV) Cash from Financing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Financing Activities data on file, last reported at -$1.5 billion in Q2 2026.

• On a quarterly basis, Cash from Financing Activities fell 385.06% year-over-year to -$1.5 billion in Q2 2026; TTM through Jun 2026 was -$3.5 billion, a 104.76% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 billion, down 245.68% from the prior year.
• Cash from Financing Activities for Q2 2026 stood at -$1.5 billion, up from -$2.5 billion in the prior quarter.
• Over the last five years, Cash from Financing Activities for ELV reached as high as $1.4 billion in Q4 2024 and fell as low as -$2.5 billion in Q1 2026.
• Historically, Cash from Financing Activities has averaged -$512.3 million across 5 years, with a median of -$351.0 million in 2023.
• Across the five-year window, Cash from Financing Activities soared 457.36% in 2024 and slumped 6065.62% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$258.0 million in 2022, then slumped by 52.71% to -$394.0 million in 2023, then surged by 457.36% to $1.4 billion in 2024, then tumbled by 83.24% to $236.0 million in 2025, then tumbled by 733.05% to -$1.5 billion in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.5 billion in Q2 2026, -$2.5 billion in Q1 2026, and $236.0 million in Q4 2025.